In the News: Ohio State College of Engineering Spotlights Pavaka's Path to Commercialization
Updated: 5 days ago
COLUMBUS, Ohio — February 24, 2025 — The Ohio State University College of Engineering has published a feature on Pavaka Wound Care, "Electroceutical innovation wound care tech nears commercialization." It follows the Department of Mechanical and Aerospace Engineering's January story on the company's exclusive license.
The article traces the technology from Ohio State's laboratories to Pavaka. It credits the interdisciplinary research team led by Mechanical and Aerospace Engineering Professor Shaurya Prakash, which included Professor of Microbial Infection and Immunity Daniel Wozniak, MAE Professor Emeritus Vish Subramaniam, the late Professor Paul Stoodley and former Professor of Pathology Traci Wilgus, supported by students and staff.
The College frames the work against the global challenge of antimicrobial resistance. It cites the estimated 1.27 million deaths each year attributed to resistant infections and notes that the Department of Defense has highlighted the issue's potential impact on military readiness.
"With this technology, we're addressing a critical unmet need in wound care," Pavaka CEO and Co-Founder Brent Toto told the College. "This partnership allows us to transform a decade of groundbreaking research into a solution that can change lives, while also contributing to Ohio's growing biotechnology sector."
The article also quotes Paco Herson, associate vice president for Health Sciences Innovation in Ohio State's Enterprise for Research, Innovation and Knowledge. "We're proud to see our research lead to innovations that directly improve patient care," Herson said. "By partnering with Pavaka Wound Care, we're excited to see this technology transition from the lab to helping individuals who need it most."
As the College notes, Pavaka is committed to further research, development and manufacturing of the electroceutical wound dressing in Ohio, with longer-term interest in veterinary and military health applications. The dressing generates a low-level electric field at the wound surface and remains investigational.
The Department of Mechanical and Aerospace Engineering later included its January 2025 Pavaka story among its top stories of 2025.
"Ohio State has been a true partner from the lab bench to the license. We're grateful the College chose to tell this story, and we intend to make Ohio proud as we build the company here." — Brent Toto, CEO and Co-Founder
Investigational device: Pavaka's electroceutical wound dressing has not been cleared or approved by the U.S. Food and Drug Administration and is not available for sale.
About Pavaka Wound Care: Pavaka Wound Care is a Columbus, Ohio–based medical device company developing an electroceutical advanced wound dressing for chronic and acute wounds, including wounds complicated by multidrug-resistant bacteria and biofilms. Built on technology exclusively licensed from The Ohio State University, the investigational dressing generates a low-level electric field at the wound surface. Pavaka was co-founded by CEO Brent Toto and CTO Frank Fischer. Learn more at www.pavakawoundcare.com.




Comments